RT Journal Article
SR Electronic
T1 Chronic lung diseases: entangled in extracellular matrix
JF European Respiratory Review
JO EUROPEAN RESPIRATORY REVIEW
FD European Respiratory Society
SP 210202
DO 10.1183/16000617.0202-2021
VO 31
IS 163
A1 Janette K. Burgess
A1 Martin C. Harmsen
YR 2022
UL http://err.ersjournals.com/content/31/163/210202.abstract
AB The extracellular matrix (ECM) is the scaffold that provides structure and support to all organs, including the lung; however, it is also much more than this. The ECM provides biochemical and biomechanical cues to cells that reside or transit through this micro-environment, instructing their responses. The ECM structure and composition changes in chronic lung diseases; how such changes impact disease pathogenesis is not as well understood. Cells bind to the ECM through surface receptors, of which the integrin family is one of the most widely recognised. The signals that cells receive from the ECM regulate their attachment, proliferation, differentiation, inflammatory secretory profile and survival. There is extensive evidence documenting changes in the composition and amount of ECM in diseased lung tissues. However, changes in the topographical arrangement, organisation of the structural fibres and stiffness (or viscoelasticity) of the matrix in which cells are embedded have an undervalued but strong impact on cell phenotype. The ECM in diseased lungs also changes in physical and biomechanical ways that drive cellular responses. The characteristics of these environments alter cell behaviour and potentially orchestrate perpetuation of lung diseases. Future therapies should target ECM remodelling as much as the underlying culprit cells.Important biochemical and biomechanical cues from the extracellular matrix are disrupted in chronic lung diseases, altering the fate of resident lung cells and trafficking immune cells, and thereby contributing to disease development and progression https://bit.ly/3FgiQvc